Sep'05 | Sep'06 | Sep'07 | Sep'08 | Sep'09 | Sep'10 | Sep'11 | Sep'12 | Sep'13 | Sep'14 | Sep'15 | Sep'16 | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | $32.6M | $50.3M | $147.8M | ($197.5M) | ($2,016.7M) | $69.9M | $374.4M | $113.7M | ($906.3M) | $279.7M | $455.1M | $548.6M | $1,370.2M | ($237.9M) | $134.4M | $1,105.0M | $2,480.3M | $1,640.2M | $668.4M | $882.6M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Hologic, Inc.'s last 12-month Operating Income is $935.5M, based on the financial report for Sep 28, 2024 (Q3 2024).
Over the last year, Hologic, Inc.'s Operating Income growth was 40.0%. The average annual Operating Income growth rates for Hologic, Inc. have been (28.0%) over the past three years, 89.2% over the past five years.